As of 2024-12-15, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is -1.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is 78.37 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is -59.15 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 6.9x | 6.9x |
| Forward P/E multiples | 6.8x - 6.9x | 6.9x |
| Fair Price | (4.75) - (4.81) | (4.81) |
| Upside | -384.6% - -388.4% | -388.4% |
| Date | EV/EBITDA |
| 2024-12-09 | -1.61 |
| 2024-12-06 | -1.58 |
| 2024-12-05 | -1.53 |
| 2024-12-04 | -1.55 |
| 2024-12-03 | -1.56 |
| 2024-12-02 | -1.65 |
| 2024-11-29 | -1.73 |
| 2024-11-28 | -1.66 |
| 2024-11-27 | -1.73 |
| 2024-11-26 | -1.70 |
| 2024-11-25 | -1.51 |
| 2024-11-22 | -1.47 |
| 2024-11-21 | -1.45 |
| 2024-11-20 | -1.48 |
| 2024-11-19 | -1.53 |
| 2024-11-18 | -1.47 |
| 2024-11-15 | -1.48 |
| 2024-11-14 | -1.51 |
| 2024-11-13 | -1.56 |
| 2024-11-12 | -1.50 |
| 2024-11-11 | -1.42 |
| 2024-11-08 | -1.45 |
| 2024-11-07 | -1.42 |
| 2024-11-06 | -1.43 |
| 2024-11-05 | -1.43 |
| 2024-11-04 | -1.47 |
| 2024-11-01 | -1.43 |
| 2024-10-31 | -1.45 |
| 2024-10-30 | -1.45 |
| 2024-10-29 | -1.49 |
| 2024-10-28 | -1.49 |
| 2024-10-25 | -1.50 |
| 2024-10-24 | -1.52 |
| 2024-10-23 | -1.50 |
| 2024-10-22 | -1.53 |
| 2024-10-21 | -1.56 |
| 2024-10-18 | -1.61 |
| 2024-10-17 | -1.60 |
| 2024-10-16 | -1.59 |
| 2024-10-15 | -1.60 |
| 2024-10-14 | -1.60 |
| 2024-10-11 | -1.64 |
| 2024-10-10 | -1.64 |
| 2024-10-09 | -1.71 |
| 2024-10-08 | -1.63 |
| 2024-10-07 | -1.58 |
| 2024-10-04 | -1.57 |
| 2024-10-03 | -1.58 |
| 2024-10-02 | -1.64 |
| 2024-10-01 | -1.74 |